Pulmonary Neoplasms Clinical Trial
Official title:
Clinical Effectiveness of a Balloon Covered Sheath as a Guide Sheath in Endobronchial Ultrasound Guided Diagnosis of Peripheral Lung Lesions
The purpose of this study is to examine the usefulness of a balloon covered sheath as a guide sheath in endobronchial ultrasound guided transbronchial biopsy and bronchial brushing cytology for diagnosis of peripheral lung lesions
Flexible bronchoscopy has been applied in the diagnosis of peripheral pulmonary lesions
(PPLs) for decades. Without accurate localization, the diagnostic yield for peripheral lung
cancers by these procedures is limited and variable. Localization of peripheral lung cancers
can be aided by the use of computed tomography or fluoroscopy during fiberoptic
bronchoscopy. However, radiation exposure to staffs and patients is always a concern in
these procedures.
The clinical application of endobronchial ultrasound (EBUS) included determination of the
depth of tumor invasion in tracheobronchial wall, evaluation of tracheobronchial structure
before therapeutic bronchoscopy, localization of site of biopsy, EBUS-guided transbronchial
needle aspiration, and analysis of peripheral tumor. Under EBUS guidance, the diagnostic
yield of transbronchial lung biopsy in patients with peripheral lung cancer by bronchoscopic
examination was significantly improved without an increase in the complication rate. More
recently, with the aid of a guide sheath (EBUS-GS), EBUS has been shown to increase the
diagnostic yield of PPLs, even in patients with fluoroscopy-invisible lung nodules, and
avert the need for surgical procedures.
Most recently used GS for EBUS are specified for the EBUS probe with an external diameter of
1.9 mm. Such a thin caliber GS is designed to reach the PPLs, sometimes with an aid of
curette, to provide an exact site for repeated obtainment of adequate specimens. We wonder
whether a larger caliber sheath transformed from a balloon covered with an external diameter
of 2.6 mm without reaching the PPLs, can offer similar effectiveness in diagnosis of the
PPLs. The results may provide an alternative way for EBUS-GS especially in those countries
where the commonly used GS of EBUS is not available.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01860898 -
A Phase I Study of iPS Cell Generation From Patients With COPD
|
N/A | |
Completed |
NCT05011890 -
Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®
|
N/A | |
Completed |
NCT00290953 -
Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide
|
Phase 2/Phase 3 | |
Completed |
NCT00132639 -
Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)
|
Phase 2 | |
Terminated |
NCT00241267 -
Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease
|
N/A | |
Terminated |
NCT02673021 -
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
|
N/A | |
Terminated |
NCT00232128 -
Protocol for Radiofrequency Ablation of Pulmonary Neoplasms
|
N/A | |
Completed |
NCT00042679 -
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.
|
Phase 2 | |
Not yet recruiting |
NCT05857995 -
Precision Lung Cancer Survivorship Care Intervention
|
N/A | |
Recruiting |
NCT04699188 -
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
|
Phase 1/Phase 2 | |
Completed |
NCT02410603 -
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
|
||
Recruiting |
NCT02549638 -
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
|
||
Completed |
NCT02483052 -
RejuvenAir Lobectomy for Safety and Histology
|
Phase 1/Phase 2 | |
Completed |
NCT02370303 -
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
|
||
Completed |
NCT01470248 -
Study of Arsenic Trioxide in Small Cell Lung Cancer
|
Phase 2 |